Keyphrases
Disease Burden
100%
Hospitalized Patients
100%
Epidemiology
100%
Gram-negative Sepsis
100%
Carbapenem-resistant Enterobacteriaceae
100%
Carbapenem-resistant Gram-negative
100%
Carbapenem Resistance
66%
Non-Enterobacteriaceae
66%
Sepsis
50%
Confidence Interval
33%
Hospital Survival
33%
Enterobacter
33%
Systemic Inflammatory Response
16%
Risk Factors
16%
Retrospective Cohort Study
16%
Hazard Ratio
16%
Clinical Outcomes
16%
Clinically Significant
16%
Increased Incidence
16%
Adjusted Hazard Ratio
16%
Tertiary Care
16%
Paucity
16%
Academic Medical Centers
16%
Cystic Fibrosis
16%
Public Health Risk
16%
Single Center
16%
Risk Outcomes
16%
Cox Regression
16%
Incidence Rate
16%
Targeted Treatment
16%
Exclusion Criteria
16%
Confounding Factors
16%
Response Criteria
16%
Cochran-Armitage Trend Test
16%
Gram-negative Bacilli
16%
Carbapenem-resistant Gram-negative Infections
16%
Medicine and Dentistry
Cohort Effect
100%
Carbapenem
100%
Gram Negative Sepsis
100%
Diseases
100%
Carbapenem-Resistant Enterobacteriaceae
85%
Enterobacteriaceae
57%
Sepsis
42%
Infection
28%
Hazard Ratio
28%
Enterobacter
28%
Serositis
14%
Tertiary Care
14%
Targeted Therapy
14%
Retrospective Cohort Study
14%
Proportional Hazards Model
14%
Cystic Fibrosis
14%
Public Health
14%
Gram-Negative Bacteria
14%
Gram-Negative Bacterial Infection
14%
Pharmacology, Toxicology and Pharmaceutical Science
Carbapenem
100%
Gram Negative Sepsis
100%
Diseases
100%
Epidemiology
100%
Carbapenem Resistant Enterobacteriaceae
85%
Enterobacteriaceae
57%
Sepsis
42%
Infection
28%
Enterobacter
28%
Cohort Study
14%
Inflammation
14%
Cystic Fibrosis
14%
Gram Negative Bacterium
14%
Gram Negative Infection
14%